First human tests begin for potential new hives treatment pill
Knowledge-focused
Recruiting now
This is a very early, first-in-human study to check if a new oral drug called HRS-3095 is safe and how it behaves in the body. It involves healthy volunteers, not people with the condition it's intended for (chronic hives). The main goal is to understand the drug's safety profile…
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC